Weekly rapamycin may blunt muscle gains in older adults despite exercise

Original: We Spent $724,637 Testing Rapamycin. What We Found Shocked Us.

24
Pro
55
Against
10 claims

TL;DR

Evidence suggests weekly rapamycin at 6 mg may interfere with exercise-induced muscle improvements in older adults.

Quick Answer

The study found that weekly rapamycin (6 mg) combined with exercise did not improve muscle function in adults aged 65–85 and may have actually blunted gains compared to placebo. While both groups improved due to exercise, the rapamycin group showed statistically significant attenuation in functional improvements in sensitivity analyses. This contradicts the 'cycling hypothesis' that rapamycin could enhance exercise benefits by periodically inhibiting mTOR to boost autophagy.

Claims (10)

1. Doing the 30-second chair stand test—standing up and sitting down as many times as you can in half a minute—can accurately show how strong your legs are and how well they work as you get older.

78·083 studiesView Evidence →

2. Sirolimus stays in your body for a long time—about 2.5 days—so even if you take it just once a week, it might still be active when you work out again.

73·3683 studiesView Evidence →

3. Taking rapamycin, even in small doses now and then, might increase the chance of getting serious infections like pneumonia in older people because it can weaken the immune system.

73·6473 studiesView Evidence →

4. Rapamycin might help older animals keep their muscle and stay lean by tweaking a key cell signal involved in aging.

19·982 studiesView Evidence →

5. Taking rapamycin between workouts might help your muscles clean out junk and rebuild stronger as you age — like getting the best of both rest and exercise.

11·7393 studiesView Evidence →

6. If we block a certain protein in the body for a few weeks, it might calm down long-term inflammation in older tissues and help them work better again — possibly by waking up old stem cells and improving the immune system.

0·7381 studyView Evidence →

7. As we get older, a protein in our muscles called mTORC1 can become overactive, which slows down the body's cleanup process for damaged parts inside cells. Taking rapamycin might help turn that cleanup process back on.

0·7391 studyView Evidence →

8. Taking a weekly 6 mg dose of rapamycin might actually slow down strength gains in older people who are working out, even though both those on and off the drug get a bit stronger.

0·7392 studiesView Evidence →

9. Taking a lot of rapamycin each week might make it harder for older people to build muscle from exercise, but a smaller dose could be better for strength and body health.

0·7372 studiesView Evidence →

10. Taking rapamycin with exercise might help improve muscle strength in older people by affecting a specific cell pathway in the body.

0·73102 studiesView Evidence →
Scroll for more claims

Key Takeaways

  • Problem: As people age, their muscles don’t respond as well to exercise due to overactive mTOR, which blocks cellular cleanup (autophagy).
  • Core methods: Weekly rapamycin (6 mg), home-based exercise (three times per week), and a 12-week study duration.
  • How methods work: Rapamycin blocks mTOR to allow autophagy (cellular cleanup), and exercise is meant to rebuild muscle after; the idea was to separate these in time to get both benefits.
  • Expected outcomes: The rapamycin group improved less in muscle function than the placebo group, suggesting rapamycin interfered with exercise benefits.
  • Implementation timeframe: Effects were measured over 12 weeks, with rapamycin taken once weekly after exercise sessions.

Overview

Age-related muscle decline (sarcopenia) is linked to mTORC1 overactivation and impaired autophagy. The 'cycling hypothesis' proposes that intermittent rapamycin use could enhance muscle function by periodically inhibiting mTORC1 to promote autophagy, followed by exercise to stimulate rebuilding. This study tested this hypothesis in a 12-week, double-blind, placebo-controlled trial in 40 older adults using weekly 6 mg rapamycin and a thrice-weekly home exercise program. The goal was to determine if rapamycin could amplify exercise benefits, but results instead indicated functional blunting.

Key Terms

mTORC1 inhibitionautophagysarcopeniaper-protocol analysispharmacokinetics

How to Apply

  1. 1.Step 1: Enroll adults aged 65–85 who are not currently on a regular exercise program and randomize them to receive either 6 mg rapamycin or placebo once weekly.
  2. 2.Step 2: Deliver exercise bikes to participants’ homes and instruct them to perform moderate-intensity cycling for 30–45 minutes on days 1, 3, and 5 of each week.
  3. 3.Step 3: Administer rapamycin or placebo on day 6 of each week for 12 weeks, ensuring double-blinding and using enteric-coated capsules (e.g., Rapamune) to ensure consistent absorption.
  4. 4.Step 4: Measure muscle function using the 30-second chair stand test, 6-minute walk test, and hand grip strength at baseline and week 12.
  5. 5.Step 5: Collect blood samples to assess safety markers including CRP, HbA1c, and adverse events, with special attention to infections and metabolic changes.

Participants will show improvements in muscle function due to exercise, but those taking weekly rapamycin at 6 mg are likely to show smaller gains compared to placebo, particularly in chair stand performance, due to mTORC1 inhibition interfering with exercise-induced muscle adaptation.

Studies from Description (1)